Labshake search
Citations for Bio X Cell :
1 - 50 of 190 citations for Lifeink 200 Collagen Bioink since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2022Quote: ... αCD8 (200 μg; 2.43, BioXcell) or αCD4 (200 μg ...
-
bioRxiv - Cancer Biology 2019Quote: ... anti-PD1 (200 μg/kg, BioXcell), and/or anti-B7-H4 (200 μ.g/mouse ...
-
bioRxiv - Cancer Biology 2022Quote: ... or αCD4 (200 μg; GK1.5, BioXcell) antibody twice per week ...
-
bioRxiv - Immunology 2022Quote: ... rat IgG2a (2A3; BioXcell; 200 μg) was used ...
-
bioRxiv - Immunology 2022Quote: ... rat IgG2a (2A3; BioXcell; 200 μg) was used ...
-
bioRxiv - Immunology 2022Quote: ... rat IgG2a (2A3; BioXcell; 200 μg) was used ...
-
bioRxiv - Cancer Biology 2023Quote: ... or αCD8 (200 μg; 2.43, BioXcell) antibody twice per week ...
-
bioRxiv - Cancer Biology 2022Quote: ... IgG (BioXcell, LTF-2; 200 µg, i.p.) bi-weekly ...
-
bioRxiv - Cancer Biology 2022Quote: ... or αCXCR3 (200 μg; CXCR3-173, BioXcell) antibody twice per week ...
-
bioRxiv - Neuroscience 2021Quote: ... with 200 ug anti-CD4 (GK1.5, BioXCell) or isotype control antibody (LTF-2 ...
-
bioRxiv - Immunology 2019Quote: ... with 200 ug anti-NK1.1 (PK136, BioXCell) or 50 ug LEAF purified anti-NKp46 (Biolegend) ...
-
bioRxiv - Cancer Biology 2020Quote: ... 200 αPD-1 (BioXCell, clone 29F.1A12) or a combination of the checkpoint inhibitor and the immunocytokine ...
-
bioRxiv - Cancer Biology 2021Quote: ... 200 µg of anti-CD8 (BioXCell BE0117) and 200 µg of anti-CD4 (BioXCell BE0003-1) ...
-
bioRxiv - Immunology 2021Quote: ... 200 μg of anti-NKG2D (HMG2D, BioXcell) or Armenian hamster IgG (BioXcell ...
-
bioRxiv - Immunology 2023Quote: Anti-SIRPα (clone P84; 200 μg; BioXCell) antibody was diluted in PBS and administered to mice via intraperitoneal injection on days 7 and 9 post- induction for day 10 harvest ...
-
bioRxiv - Immunology 2024Quote: ... 200 μg of the clone 4RA10 (Bioxcell) was injected prior infection for the studies in the spleen ...
-
bioRxiv - Immunology 2022Quote: ... Neutrophil recruitment modulation has been performed by treating intraperitoneally with 200 µg/200 µl of anti-Ly6G depleting antibody (InVivoPlus 1A8; BioXcell) or control isotype (InVivoPlus rat IgG2a ...
-
bioRxiv - Cancer Biology 2021Quote: ... 200 µg of anti-PD-1 (BioXCell BE0146) and 200 µg of anti-CTLA-4 (BioXCell BE0164) ...
-
bioRxiv - Cancer Biology 2021Quote: ... 200 µg of anti-PD-1 (BioXCell BE0146), or 300 µg of anti-IgG2b (BioXCell BE0090) ...
-
bioRxiv - Cancer Biology 2021Quote: ... 200 μg of anti-CD8α (53-6.7, BioXcell) or isotype control (2A3 ...
-
bioRxiv - Cancer Biology 2022Quote: ... anti-PD1 (BioXcell, RMP1-14; 200 µg, i.p.) bi-weekly ...
-
bioRxiv - Cancer Biology 2022Quote: ... or α-CD8 antibody (200 μg; 2.43, BioXcell) twice per week ...
-
bioRxiv - Cancer Biology 2022Quote: ... isotype control antibody (200 μg; LTF-2, BioXcell) was IP twice per week ...
-
bioRxiv - Immunology 2019Quote: ... and α-CD28 (200 ng/mL; 9.3; BioXCell) on goat-α-mouse (10 µg/mL ...
-
bioRxiv - Immunology 2022Quote: ... αPD-1 (RMP1-14; BioXcell; 200 μg/dose) was injected intraperitoneally (i.p. ...
-
bioRxiv - Bioengineering 2023Quote: ... or 200 μg anti-CD8α antibody (BioXcell, BE0061) on days 7 ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 200 µg of anti-CTLA-4 (BioXCell BE0164), or 400 µg of anti-IgG2b isotype control (BioXCell BE0090) ...
-
bioRxiv - Cancer Biology 2021Quote: ... and 200 µg of anti-CD4 (BioXCell BE0003-1), or 400 µg of anti-IgG2b isotype control (BioXCell BE0090) ...
-
bioRxiv - Immunology 2020Quote: ... 200 µg αPD-1 (clone 29 F.1A12, BioXCell) or 200 µg isotype-matched control antibody (Rat IgG2a ...
-
bioRxiv - Cancer Biology 2022Quote: ... and 200 μg anti-CTLA-4 (clone 9H10, BioXcell), or their respective IgG controls ...
-
bioRxiv - Cancer Biology 2022Quote: ... 200 μg anti-PD-1 (clone RMP1-14, BioXcell) and 200 μg anti-CTLA-4 (clone 9H10 ...
-
bioRxiv - Cancer Biology 2020Quote: ... α-PD-1 antibody (200 μg; RMP1-14, BioXcell) was used ...
-
bioRxiv - Cancer Biology 2020Quote: ... 200 μg rat anti-mouse PD1 (Bio X Cell) or 200 μg rat IgG2a isotype control (Bio X Cell) ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-CTLA4 mAb (200 µg/mouse; clone 9D9, BioXcell), anti-PD1 mAb (200 µg/mouse ...
-
bioRxiv - Immunology 2020Quote: ... and 200 μg/mouse anti-TRP1 antibody (TA99; BioXCell). For adoptive cell transfer ...
-
bioRxiv - Immunology 2021Quote: ... or 200 µg isotype control antibody (Rat IgG2a, BioXcell) were diluted in PBS at 1 mg/ml and administered by intra-peritoneal (i.p. ...
-
bioRxiv - Immunology 2021Quote: ... 200 µg CTLA4-Ig (Bio X Cell Cat BE0099) was administered intraperitoneally on post-transplant days 0 ...
-
bioRxiv - Immunology 2022Quote: ... 15 and αCTLA-4 (9H10; BioXcell; 200 μg/dose) on days 0 ...
-
bioRxiv - Immunology 2023Quote: ... with 200 μg anti-IFN-γ (clone XMG1.2, BioXCell) on days 0 ...
-
bioRxiv - Immunology 2023Quote: ... 200 µg of anti-IL-18 neutralizing antibody (BioXcell) or isotype control (IgG2a ...
-
bioRxiv - Immunology 2024Quote: ... 200 µg anti-NK1.1 mAb (clone PK136, BioXcell, US) was administered i.p ...
-
bioRxiv - Immunology 2024Quote: ... or anti-CD4 antibody (200 μg, clone GK1.5, BioXcell) by i.p ...
-
bioRxiv - Immunology 2020Quote: ... or 200 µg isotype-matched control antibody (Rat IgG2a, BioXCell) were given intraperitoneally on day 11 ...
-
bioRxiv - Immunology 2019Quote: ... with 200 μg of anti-NK1.1 (PK136, Bio X Cell) 1 d before infection (d −1) ...
-
bioRxiv - Cancer Biology 2020Quote: ... or 200 μg rat IgG2a isotype control (Bio X Cell). Mice were dosed by intraperitoneal injection commencing on day 3 and antibody administration was repeated every 3 days until the end of the study ...
-
bioRxiv - Immunology 2022Quote: ... 200 μg anti-mouse CD8 (clone 2.43; Bio X Cell) antibodies were intraperitoneally administered twice per week starting the day of tumor implantation.
-
bioRxiv - Immunology 2019Quote: ... 200 µg of antibodies (anti-mCD8α clone 53-6.72, BioXCell or Rat IgG2a Isotype control ...
-
bioRxiv - Cancer Biology 2021Quote: ... anti-PD1 mAb (200 µg/mouse; clone RMP1-14, BioXcell), alone or in combinations until endpoint or one week after tumor clearance ...
-
bioRxiv - Immunology 2020Quote: ... or 200 μg of Armenian Hamster IgG isotype control (BioXCell) at the indicated time points ...
-
bioRxiv - Immunology 2019Quote: ... with 200 μg of anti-NK1.1 (PK136, Bio X Cell). To block NKp46 mice were treated i.p ...